Evid Invest
Holders — by stockHoldings — by fund

Atle Fund Management AB

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001381843

$373.4M

disclosed book value

39

positions

9.7%

largest position share

Positions, as of 2026-09-30

top 39 of 39 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1LLYELI LILLY & CO31,202$36.1M9.7%
2MRKMERCK & CO. INC168,987$24.6M6.6%
3JNJJOHNSON & JOHNSON91,387$24.2M6.5%
4ABBVABBVIE INC91,294$23.9M6.4%
5TMOTHERMO FISHER SCIENTIFIC CORP34,410$23.2M6.2%
6BIIBBIOGEN INC70,955$16.0M4.3%
7VRTXVERTEX PHARMACEUTICALS INC28,157$14.7M3.9%
8RVMDREVOLUTION MEDICINES INC66,113$13.6M3.6%
9ONCBEONE MEDICINES LTD-ADR35,679$13.1M3.5%
10CVSCVS HEALTH CORP139,311$11.9M3.2%
11CORCENCORA INC36,107$10.8M2.9%
12BBIOBRIDGEBIO PHARMA INC163,697$10.8M2.9%
13ISRGINTUITIVE SURGICAL INC25,648$10.4M2.8%
14INSMINSMED INC87,469$10.0M2.7%
15EWEDWARDS LIFESCIENCES CORP109,647$9.5M2.5%
16SYKSTRYKER CORPORATION34,296$9.4M2.5%
17INCYINCYTE CORP77,377$9.4M2.5%
18KRYSKRYSTAL BIOTECH, INC28,074$9.3M2.5%
19DXCMDEXCOM INC89,251$7.7M2.1%
20NAMSNEWAMSTERDAM PHARMA CO NV303,824$7.4M2%
21IRTCIRHYTHM TECHNOLOGIES INC54,102$6.1M1.6%
22GILDGILEAD SCIENCES INC40,461$6.0M1.6%
23MIRMMIRUM PHARMACEUTICALS INC70,071$6.0M1.6%
24CAHCARDINAL HEALTH INC26,735$5.9M1.6%
25BSXBOSTON SCIENTIFC130,622$5.7M1.5%
26ALKSALKERMES PLC136,225$5.5M1.5%
27NBIXNEUROCRINE BIOSCIENCES INC38,611$5.5M1.5%
28TNGXTANGO THERAPEUTICS INC184,394$4.6M1.2%
29ABVXABIVAX SA46,452$4.6M1.2%
30SYRESPYRE THERAPEUTICS INC44,243$3.9M1.1%
31ORKAORUKA THERAPEUTI43,180$3.6M1%
32IDYAIDEAYA BIOSCIENCES INC93,550$3.6M1%
33SMMTSUMMIT THERAPEUTICS INC184,687$3.1M0.8%
34CMPSPATHWAYS PLC243,506$3.0M0.8%
35IRONDISC MEDICINE INC43,682$2.9M0.8%
36CELCCELCUITY INC29,893$2.4M0.6%
37PVLAPALVELLA THERAPEUTICS INC NE14,924$2.1M0.6%
38PYXSPYXIS ONCOLOGY INC663,772$1.5M0.4%
39MANEVERADERMICS INC10,106$1.2M0.3%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.